BLISSGVS.BO
BLISSGVS.BO
INE416D01022
BLISS GVS PHARMA LTD.
Loading chart...

Company Profile

-

Related stocks

MOREPENLAB.NS
MOREPENLAB.NS • India
MOREPEN LAB. LTD
129.55 INR
733.49M USD 1Y +170.4%
SPARC.NS
SPARC.NS • India
SUN PHARMA ADV.RES.CO.LTD
185.6 INR
622.35M USD 1Y +46.6%
IOLCP.BO
IOLCP.BO • India
IOL CHEMICALS & PHARMACEUTICAL
200.85 INR
609.17M USD 1Y +100.2%
AKUMS.NS
AKUMS.NS • India
AKUMS DRUGS AND PHARMA L
751.85 INR
1.19B USD 1Y +78.6%
4887.T
4887.T • Japan
SAWAI GROUP HOLDINGS CO LTD
1,629.5 JPY
1.19B USD 1Y -18.6%
6185.HK
6185.HK • China
CANSINOBIO
35.02 HKD
1.1B USD 1Y -28.6%
AARTIPHARM.NS
AARTIPHARM.NS • India
AARTI PHARMALABS LIMITED
855.5 INR
801.58M USD 1Y +2.5%
STAR.NS
STAR.NS • India
STRIDES PHARMA SCI LTD
1,085.3 INR
1.03B USD 1Y +37.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
India
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
50.1% p.a.
Max Drawdown (5Y)
-41.3%
Sharpe Ratio (5Y)
0.80
Beta Factor
1.22
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 51.2 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (56.9%) is noticeably higher than the 5Y average (50.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.9% in the extended horizon.
ende